CTMX offering history
Every offering-related filing in CytomX Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 797 filings back to Sep 28, 2010.
| Date | Filing | What it means | |
|---|---|---|---|
| Mar 18, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 16, 2026 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Mar 16, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 18, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 7, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 12, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 19, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 9, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 28, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 25, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 16, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 3, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 4, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 18, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 17, 2021 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Aug 5, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 21, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 19, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 27, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 8, 2019 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 11, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 6, 2019 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 6, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 13, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 10, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 3, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 20, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 9, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 7, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 23, 2016 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 3, 2016 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 8, 2015 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 7, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 6, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 2, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 28, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 18, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 11, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Aug 28, 2015 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
CTMX offering FAQ
When did CTMX last execute an offering?
Per SEC filings, CytomX Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-03-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did CTMX last announce or register an offering?
The most recent registration is a S-3ASR filed 2026-03-16. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.